Funded Tech Companies
Code Biotherapeutics
Researching who provided funding to Code Biotherapeutics? Amgen Ventures, Takeda Ventures and UCB S.A. invested in this biopharmaceutical company.
Company Overview
Company Name
Code Biotherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2801 Sterling Dr.
Hatfield, PA 19440
USA
Hatfield, PA 19440
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Code Bio was founded on the belief that so much more can be done for people living with debilitating genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/7/2022
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian McVeigh
Chief Technical Officer
Robert Getts
Vice President
Lori Getts
VP - Bus. Development
Lauren Kaskiel
Company Investors
- Amgen Ventures
- Takeda Ventures
- UCB S.A.
- UPMC Enterprises
- New Enterprise Associates
- Hatteras Venture Partners
- 4BIO Capital (Dima Kuzmin)
- Northpond Ventures (Diana Bernstein)
- CureDuchenne Ventures (Debra Miller)
- JDRF T1D Fund
- UPMC Health Plan (Robert Lin)
Browse more funded tech companies:
Code 42 Software | Code Climate
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs